A randomized controlled trial comparing tadalafil/solifenacin versus tamsulosin/solifenacin combination for the treatment of benign prostatic hyperplasia with overactive bladder

被引：0
|
作者：
Hegazy, M. [1 ]
Ashour, R. [1 ]
Ramez, M. [1 ]
Wadie, B. S. [1 ]
Nabeeh, A. [1 ]
El-Hefnawy, A. S. [1 ]
机构：
[1] Urol & Nephrol Ctr, Dept Urol, Mansoura, Egypt
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0806
引用
收藏
页码：S1805 / S1806
页数：2
相关论文
共 50 条
  • [21] Who Would Bener Symptoms Associated with Benign Prostatic Hyperplasia?efit from Solifenacin Add-On Therapy to Tamsulosin for Overactive Bladd
    Obata, Jun
    Matsumoto, Kazuhiro
    Yamanaka, Hiroyuki
    Ninomiya, Akiharu
    Nakamura, So
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2013, 5 (03) : 145 - 149
  • [22] A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms
    Ciayadi, Tjia Adynata
    Palinrungi, Muhammad Asykar
    Kholis, Khoirul
    Hendarto, Joko
    Syahrir, Syakri
    Syarif, Syarif
    Azis, Abdul
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2023, 46
  • [23] Effect of tadalafil add-on therapy in patients with persistant storage symptoms refractory to α1-adrenoceptor antagonist monotherapy for benign prostatic hyperplasia: A randomized pilot trial comparing tadalafil and solifenacin
    Urakami, Shinji
    Ogawa, Kohei
    Oka, Suguru
    Hagiwara, Kiichi
    Nagamoto, Shoichi
    Anjiki, Haruki
    Hayashida, Michikata
    Yano, Akihiro
    Sakaguchi, Kazushige
    Kurosawa, Kazuhiro
    Okaneya, Toshikazu
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (03) : 109 - 114
  • [24] A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms
    EL-Nahas, Ahmed R.
    Tharwat, Mohamed
    Elsaadany, Mohamed
    Mosbah, Ahmed
    Gaballah, Mohamed A.
    [J]. WORLD JOURNAL OF UROLOGY, 2016, 34 (07) : 963 - 968
  • [25] Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study
    Zhang, Yumeng
    Wang, Shaoyong
    Zu, Shulu
    Zhang, Chanjuan
    [J]. PLOS ONE, 2021, 16 (06):
  • [26] PHARMACOECONOMIC ANALYSIS OF USING SOLIFENACIN AND MODIFIED-RELEASE TAMSULOSIN FIXED DOSE COMBINATION FOR TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
    Avxentyev, N.
    Frolov, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A488 - A489
  • [27] A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms
    Ahmed R. EL-Nahas
    Mohamed Tharwat
    Mohamed Elsaadany
    Ahmed Mosbah
    Mohamed A. Gaballah
    [J]. World Journal of Urology, 2016, 34 : 963 - 968
  • [28] TAMSULOSIN, SOLIFENACIN, AND THEIR COMBINATION FOR THE TREATMENT OF STENT-RELATED SYMPTOMS: A RANDOMIZED CONTROLLED STUDY.
    Zhou, Peng
    Zhu, Jingyu
    Li, Ruipeng
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E224 - E224
  • [29] The Add-On Effect of Solifenacin for Patients with Remaining Overactive Bladder after Treatment with Tamsulosin for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction
    Masumori, Naoya
    Tsukamoto, Taiji
    Yanase, Masahiro
    Horita, Hiroki
    Aoki, Masaharu
    [J]. ADVANCES IN UROLOGY, 2010, 2010
  • [30] Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial
    Hsiao, Sheng-Mou
    Tu, Fung-Chao
    Su, Ta-Chen
    Wu, Pei-Chi
    Lin, Ho-Hsiung
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
12345